Invitae
NVTA
$0.01950
Share price
0.00%
Change (1 day)
-98.61%
Change (1 year)
Invitae (NVTA) - P/B ratio
P/B ratio as of May 2024 : -0.0052
According to Invitae
's latest financial reports the company has a price-to-book ratio of -0.0052.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.
Invitae - P/B ratio (from 2015 to 2023)
P/B ratio by year
| Year | P/B ratio | Change |
|---|---|---|
| 2023-12-31 | -0.1657 | -103.74% |
| 2022-12-31 | 4.44 | 282.26% |
| 2021-12-31 | 1.16 | -68.95% |
| 2020-12-31 | 3.74 | -10.94% |
| 2019-12-31 | 4.20 | -18.62% |
| 2018-12-31 | 5.16 | 30.68% |
| 2017-12-31 | 3.95 | 51.8% |
| 2016-12-31 | 2.60 | 37.24% |
| 2015-12-31 | 1.89 | |
| 2014-12-31 | N/A | |
| 2013-12-31 | N/A |
P/B ratio for similar companies or competitors
| Company | P/B ratio | differencediff. | Country |
|---|---|---|---|
 Celldex Therapeutics CLDX | 5.75 | -111,546.97% | 🇺🇸 USA |
 HTG Molecular Diagnostics
HTGM | 0.1971 | -3,922.76% | 🇺🇸 USA |
 CareDx CDNA | 1.54 | -29,917.16% | 🇺🇸 USA |